Named on one round in the feed.
Since 2026-09-09
| Company | Round | Amount | Announced | Role |
|---|---|---|---|---|
Encoded Therapeutics Encoded Therapeutics develops gene therapies targeting genetic disorders, primarily focusing on neurological conditions. | Series F Verified against 4 of 7 sources[ REPORTED LATER ]: This round was announced before Fireround first saw it. It stays in the company's history, not in Latest, Trending, or alerts. | $275M | 2026-09-09 | [ LEAD ] |